Allogeneic Adipose-Derived Mesenchymal Stromal Cell Transplantation for Refractory Lupus Nephritis: Results of a Phase I Clinical Trial

By
Justin.choi
-
0
13
In a Phase I trial, nine biopsy-proven lupus nephritis patients refractory to standard treatments underwent systemic infusion of 2×106 allogeneic adipose-derived MSCs/kg and were followed for 12 months post-intervention.
[Current Research in Translational Medicine]

Sorry, but the selected Zotpress account can't be found.

Abstract